The following is a summary of “Evidence for improved glucose metrics and perinatal outcomes with continuous glucose ...

Once-weekly basal insulin combined with an intermittently scanned continuous glucose monitor reduced HbA1c and improved time ...

Despite major product launches from diabetes rivals last year, Abbott’s diabetes unit brought in $1.8bn total Q1 sales to ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings ...

The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with diabetes.

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

DXCM secures FDA clearance for its G7 15-Day CGM, the longest-lasting and most accurate wearable, enhancing user convenience ...

The Food and Drug Administration has cleared diabetes-management firm DexCom's new continuous glucose monitoring (CGM) system ...

A group of experts discusses the use of continuous glucose monitoring (CGM) technology in diabetes and its transformative potential in managing the disease.

The new sensor — expected to launch in the second half of 2025 — will provide easier diabetes management for eligible users.

San Diego-based Dexcom submitted its 15-day G7 CGM to the FDA in October 2024. The company says its 15-day G7 also meets ...